Tarsus Pharmaceuticals Cash Flow Statement (2019-2026) | TARS

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Operating Activities
Net Income (Quarter)	7.26M	-15.36M	-14.49M	-19.84M	-5.47M	-22.47M	-13.63M	-23.34M	-31.41M	-38.95M	-42.46M	-35.55M	-31.28M	-23.49M	-23.09M	-25.04M	-20.20M	-12.68M	-6.24M	-6.88M
Depreciation and Depletion (Quarter)	0.12M	0.10M		0.10M	0.10M	0.10M	0.13M	0.10M	0.20M	0.20M	0.25M	0.17M	0.10M	0.20M	0.19M	0.20M	0.20M	0.20M	0.25M	0.20M
Share-based Compensation (Quarter)				2.67M	3.53M	3.58M	3.67M	3.91M	5.19M	5.25M	5.48M	5.52M	7.48M	7.42M	7.40M	6.93M	8.23M	12.24M	14.31M	11.97M
Gains from Investment Securities (Quarter)		0.07M	-0.81M		0.07M	-0.07M		0.12M	0.39M	1.34M		0.40M	-0.48M	0.97M			-0.23M	0.37M	0.38M	1.93M
Cash from Operations (Quarter)	20.55M	7.11M	-12.12M	-15.29M	-4.26M	-18.61M	-10.87M	-21.97M	-23.83M	-32.36M	-39.34M	-37.79M	-14.40M	-8.65M	-22.18M	-20.65M	-29.39M	18.26M	19.33M	-24.65M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)	0.04M	-0.09M	0.29M				1.32M				0.12M	0.10M	0.10M	0.10M	0.20M	0.24M	0.20M	0.20M	0.24M	0.85M
Amortization of Deferred Charges (Quarter)				0.06M	0.04M	0.05M	0.08M	0.03M	0.03M	0.03M	0.29M	0.11M	0.10M	0.13M	0.22M	0.14M	0.15M	0.15M	0.16M	0.16M
Depreciation & Amortization (CF) (Quarter)	0.12M	0.08M	0.04M	0.04M	0.09M	0.09M	0.10M	0.10M	0.18M	0.20M	0.25M	0.17M	0.10M	0.20M	0.19M	0.20M	0.20M	0.20M	0.25M	0.20M
Change in Working Capital
Change in Receivables (Quarter)	-0.09M	-0.14M	0.07M	0.02M	0.49M	-0.49M	-0.02M	2.50M	-5.84M	8.70M	-7.85M	0.38M	12.53M	-12.86M	30.09M	0.43M	0.18M	-0.19M	37.88M	-0.19M
Change in Inventory (Quarter)										0.01M	3.09M	0.93M	0.69M	0.65M	-0.23M	0.08M	1.17M	-0.04M	0.54M	0.20M
Change in Accured Expenses (Quarter)	4.98M	-3.42M	2.67M	-0.99M	0.97M	1.21M	-0.37M	-1.05M	0.41M	5.81M	3.53M	-7.29M	2.09M	3.28M	4.46M	-5.89M	19.49M	-15.88M	9.18M	-9.25M
Other Working Capital Changes (Quarter)	-0.21M	0.56M	1.38M	-0.04M	-0.03M	-0.00M	0.80M	-0.26M	0.22M	0.03M	2.89M	-1.06M	0.83M			-8.72M	8.72M			13.24M
Investing Activities
Capital Expenditures (Quarter)	-0.17M	0.31M	-0.31M	0.16M	-0.10M	0.32M	-0.36M	0.34M	0.79M	0.38M	-1.37M		0.00M	1.49M	0.07M	0.04M	0.30M	3.16M	6.36M	5.82M
Change in Intangibles (Quarter)															5.00M
Change in Acquisitions & Divestments (Quarter)							5.32M	40.30M	64.88M	51.74M	17.85M	2.50M	10.54M	24.50M	35.47M	91.22M	79.00M	99.50M	92.08M	74.06M
Cash from Investing Activities (Quarter)	-0.02M	-0.12M	-0.27M	-0.16M	-0.12M	-57.13M	-87.22M	11.29M	64.09M	47.37M	17.85M	-102.22M	-40.52M	3.13M	-59.57M	-34.94M	-51.70M	-4.74M	49.27M	-58.56M
Financing Activities
Other financing activities (Quarter)				0.81M	0.06M									0.04M
Cash from Financing Activities (Quarter)	0.00M	0.07M	-0.07M	19.12M	74.73M	-0.14M	0.26M	5.01M	0.51M	104.89M	19.76M	108.77M	42.32M	0.64M	2.93M	136.56M	1.95M	2.56M	2.31M	1.20M
Additional items
Change in Cash (Quarter)	20.54M	7.07M	-12.47M	3.68M	70.35M	-75.87M	-97.83M	-5.66M	40.78M	119.90M	-1.73M	-31.24M	-12.61M	-4.88M	-78.83M	80.97M	-79.14M	16.08M	70.92M	-82.01M
Free Cash Flow (Quarter)	20.73M	6.80M	-11.81M	-15.45M	-4.16M	-18.93M	-10.52M	-22.31M	-24.61M	-32.74M	-37.97M	-37.79M	-14.41M	-10.14M	-22.25M	-20.69M	-29.69M	15.10M	12.97M	-30.47M
Net Cash Flow (Quarter)	20.54M	7.07M	-12.47M	3.68M	70.35M	-75.87M	-97.83M	-5.66M	40.78M	119.90M	-1.73M	-31.24M	-12.61M	-4.88M	-78.83M	80.97M	-79.14M	16.08M	70.92M	-82.01M

Research Tools

Developers

Tarsus Pharmaceuticals Cash Flow Statement (2019-2026) | TARS

Research Tools

Developers

Tarsus Pharmaceuticals Cash Flow Statement (2019-2026) | TARS

Create an account

Sign In

Reset Password